American Association Of Blood Banks, Inc.

American Association of Blood Banks, Inc., a nonprofit organization headquartered in Bethesda, Maryland, provides blood products, tissue and transfusion laboratory accreditation services, and professional membership support to federal healthcare agencies as a prime contractor on a full-and-open basis with no set-aside designations. The organization operates exclusively as a prime — 100% of its federal award footprint — and competes in standard procurement channels rather than through SBA-reserved vehicles. AABB's federal work centers on transfusion medicine, cellular therapies, patient blood management, and Clinical Laboratory Improvement Amendments (CLIA) compliance support across the federal medical system.

AABB's customer concentration is split between volume-driven relationships with military medical commands and dollar-dominant relationships with civilian health research agencies. The Department of the Navy Bureau of Medicine and Surgery and the Department of the Army Medical Command each account for 105 awards (44% of the award count) but carry only $474 thousand and $3.9 million in combined potential value, respectively — indicating recurring annual membership and accreditation renewals. By contrast, the Department of Health and Human Services Centers for Disease Control and Prevention Pittsburgh drives 96% of the combined potential value ($107.7 million) across just 8 awards, reflecting larger blood-product supply contracts. The National Institutes of Health Clinical Center (31 awards, $9 million) and the Defense Health Agency (11 awards, $8.1 million) round out the top tier. This divergence — high-volume repeating accreditation renewals paired with fewer but much larger product-supply contracts — shapes AABB's customer retention strategy across military, VA, and civilian research medical systems.

AABB's recent prime award portfolio includes a $2.98 million definitive contract with the Defense Health Agency (awarded September 2025, running through September 2030) for annual site membership in Armed Services Blood Program accreditation subscription services; a $2.86 million purchase order from the Department of Veterans Affairs (September 2023, running through September 2028) for tissue and transfusion laboratory accreditation, education, and professional membership supporting over 120 VA medical centers; and a $1.19 million purchase order from the Defense Health Agency (April 2026, running through September 2030) for red blood cells, platelets, and fresh frozen plasma at Fort Bliss, Texas. AABB also holds smaller recurring annual memberships and accreditation assessments with the NIH Clinical Center ($18 thousand to $20 thousand annually) and supplies blood products through delivery orders valued at $450 thousand to $670 thousand per order. The organization recently received a single-award Indefinite Delivery Contract from the NIH Clinical Center (awarded September 2025, running through September 2026) with a $500 thousand ceiling for specialized blood products and services.

The organization's prime vehicles include the Blood Safety Technical Assistance Services vehicle (7 task orders, $7.7 million combined potential value) and several IDCs with NIH Clinical Center (ceiling value $500 thousand, awarded September 2025), the Defense Health Agency, and the Veterans Affairs system. Activity has remained consistent but modest — 3 awards in 2023, 2 in 2024, 3 in 2025, 2 in 2026, and 1 in January 2027 — with only 3 awards (combined potential value $2.9 million) reaching ultimate completion in the next twenty-four months, indicating low near-term recompete exposure. AABB operates entirely through prime contracting with no named subcontractors across its federal footprint. SCI-reportable invoiced revenue was minimal ($451 thousand in FY2023 with 1.3 government-delivered FTEs), reflecting that the bulk of AABB's federal work consists of goods (blood products) and micro-purchases (annual accreditation fees under the $150 thousand SCI reporting threshold), which fall outside SCI's scope. The vendor's federal award history spans from 1984 to present across 650 total awards (including historical data) with a combined potential value of $138.7 million and combined obligated dollars of $39 million (28% of potential value).